Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
ATLANTA, Oct. 10, 2017 -- Matrix Surgical USA introduced patented (#US0D0794794) innovations designed to address two of the etiologies that most frequently cause cranial implant exposure at the CNS 2017 Annual Meeting. While computer designed and manufactured implants allow precise anatomic reconstruction of skull defects, they can be plagued by complications requiring implant removal.
“Cranial implant exposure is not uncommon and results in significant, avoidable patient morbidity and expense,” said Dr. Michael J. Yaremchuk, Chief of Craniofacial Surgery, Massachusetts General Hospital. Dr. Yaremchuk designed the cranioplasty innovations which are exclusively licensed to Matrix Surgical.
Affixing Cranial Implants
The plates and screws that typically affix cranial implants to the adjacent intact cranium almost inevitably have a profile above the surface of the implant/skull interface. Matrix Surgical’s new, patented lag screw design not only eliminates the problem of prominent fixation hardware, it also streamlines and simplifies the fixation process.
During the computer design process, the surgeon has the ability to select where the oblique holes are placed in the implant that allows fixation screws to remain within the surface contour of the implant.
Integrating Subcranial Drains
Decreases in brain volume following trauma or neurosurgery can lead to the creation of a space between the surface of the brain and the cranial implant. Fluid inevitably collects in this space and is susceptible to contamination and infection.
With Matrix Surgical’s patented design, a drain hole is strategically positioned in the implant to allow passage of a removable drain between the cranial cavity and the inner surface of the skull. The drain port’s dimensions can be customized to fit the surgeon’s preferred drain.
About Matrix Surgical USA
Matrix Surgical USA is a privately owned American company dedicated to the design, production, marketing and distribution of sterile, biocompatible craniofacial implants. Matrix Surgical USA offers its products to healthcare providers in the United States and in more than 60 countries around the world. Learn more at www.MatrixSurgicalUSA.com.
Media Contact: Lynn Hood, [email protected], 678-974-2623
